Lassen, U. (2011) “A Phase I–II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas”, Acta Oncologica, 50(3), pp. 448–454. doi: 10.3109/0284186X.2010.500300.